Search

Maheshwari, Sanjiv, Harish Srikanth Kulkarni, Yad Ram Yadav, Pawan Kumar, Ruchika Mathur, Ravi Kumar Bansal, and Sonam Gupta. 2026. “Study of Platelet Indices As Markers of Retinopathy in Patients With Diabetes Mellitus.”. The Journal of the Association of Physicians of India 74 (2): 94-97.

Bhadade, Rakesh, Namdeo Dongare, Minal Harde, Rosemarie deSouza, and Ani Patel. 2026. “To Determine Vitamin B12 Deficiency in Type 2 Diabetes Mellitus Patients on Metformin Therapy.”. The Journal of the Association of Physicians of India 74 (2): 68-73.

Ghosh, Indranil, Dilip Agrahari, Sukhwinder Singh Sangha, Vineet Behera, Pavitra M Dogra, Sreenivasa Iyengar, Paul Varghese, et al. 2026. “Profile of Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Use of Cardiopulmonary Bypass Machine.”. The Journal of the Association of Physicians of India 74 (2): 52-56.

Arora, Sumit, Pogatyanatti Basavaraj, Kuldeep Kumar Ashta, Anirudh Anil Kumar, and Nishant Raman. 2026. “Drug Resistance in HIV Following First-Line ART Failure: Insights from a Cross-Sectional Study in India.”. The Journal of the Association of Physicians of India 74 (2): 38-46.

Gupta, Poonam, Anand Sharma, Ajeet Kumar Chaurasia, and Manoj Mathur. 2026. “Circadian Rhythm Disruption and Osteoporosis in Postmenopausal Women: An Observational Study from a Tertiary Care Center in India.”. The Journal of the Association of Physicians of India 74 (2): 21-26.

Shekhar, Shashank, Sandhya Gautam, Chhaya Mittal, Snehlata Verma, Priyank Garg, and Chandra Bhushan Pandey. 2026. “A Study to Assess the Prevalence, Risk Factors, and Role of Epicardial Fat Thickness in Prediction of Diabetic Retinopathy in Type 2 Diabetic Patients in a Tertiary Care Center in Western Uttar Pradesh.”. The Journal of the Association of Physicians of India 74 (2): 12-16.

Agrawal, Prabhat Kumar, Ketan K Mehta, Abhisekh Raha, Rajesh Agarwal, Amit Varshney, Amitabh Biswas, Kiran Sharadchandra Shah, et al. 2026. “A Prospective Real-World Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin Among People With Type 2 Diabetes Mellitus Who Are Intolerant to Metformin (PRISM Study).”. The Journal of the Association of Physicians of India 74 (1E): e1-e7.